Treatment of cryptosporidium infections
US5800813A · kind A · utility
10Cited by
1References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 12, 1996 |
| Grant date | Sep 1, 1998 |
| Priority date | — |
| Expiry date | Nov 12, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing symptoms associated with cryptosporidia infection in mammals including humans in which L. reuteri cells are administered to the mammal in an amount sufficient to reduce diarrhea in the animal to a normal level. Daily administration as soon as cryptosporidia infection symptom are observed optimizes results. The L. reuteri cells may also be administered prophylactically to a mammal before exposure to cryptosporidia. The cells may be administered suspended in a liquid or in dry form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.